Systemic sclerosis and scleroderma renal crisis in African American patients

Area of Science:

• Rheumatology
• Immunology
• Genetics

Background:

• Scleroderma, or systemic sclerosis (SSc), is a complex autoimmune fibrosing disease.
• Previous research indicates a disproportionately higher incidence and worse outcomes of SSc in African Americans compared to other populations.
• Scleroderma renal crisis, a severe complication, is notably more prevalent in African Americans.

Purpose of the Study:

• To investigate the associations between ethnicity, disease pathogenesis, and the complexities of systemic sclerosis.
• To explore the interplay of genetic, environmental, and social factors in the development of SSc.

Main Methods:

• Review of existing epidemiological and clinical data on SSc incidence and outcomes.
• Analysis of prevalence data for scleroderma renal crisis across different ethnic groups.
• Exploration of potential genetic, environmental, and social contributing factors.

Main Results:

• African Americans exhibit nearly twice the incidence of SSc compared to non-African Americans.
• Scleroderma renal crisis is 3.5 times more prevalent in the African American community.
• Disease severity and outcomes are generally worse in African American patients with SSc.

Conclusions:

• Ethnicity plays a significant role in the incidence, severity, and outcomes of systemic sclerosis.
• The etiology of SSc likely involves an interplay of genetic predispositions, environmental exposures, and social determinants.
• Further research is warranted to elucidate the specific mechanisms underlying these ethnic disparities in SSc.